22nd Century Group, Inc - Common Stock (XXII)
8.1300
-0.1900 (-2.28%)
NASDAQ · Last Trade: Jun 27th, 6:35 PM EDT
Detailed Quote
Previous Close | 8.320 |
---|---|
Open | 8.320 |
Bid | 7.550 |
Ask | 8.900 |
Day's Range | 7.900 - 9.100 |
52 Week Range | 0.4320 - 126.17 |
Volume | 55,298 |
Market Cap | 19.26M |
PE Ratio (TTM) | -0.0458 |
EPS (TTM) | -177.5 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 280,646 |
Chart
About 22nd Century Group, Inc - Common Stock (XXII)
22nd Century Group Inc is a biotechnology company focused on the development and commercialization of plant-based products, particularly in the areas of hemp and cannabis, as well as products that reduce nicotine levels in tobacco. The company leverages its proprietary genetic technologies to create innovative solutions within these sectors, aiming to transform the way consumers interact with tobacco and cannabis products while promoting public health. Additionally, 22nd Century seeks to advance research and product offerings that cater to a growing demand for reduced-risk alternatives and sustainability in agriculture. Read More
News & Press Releases
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · June 26, 2025
Via Benzinga · June 24, 2025
Via Stocktwits · June 13, 2025
Via Benzinga · June 11, 2025
New York, New York--(Newsfile Corp. - May 21, 2025) - Emerging Growth Research today released its latest quarterly update report...
Via Newsfile · May 21, 2025